HLVX logo

HilleVax, Inc. Common Stock


HLVX: HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.


Show HLVX Financials

Consumer Interest
SEC Filings

Recent trades of HLVX by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by HLVX's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of HLVX in WallStreetBets Daily Discussion


Recent insights relating to HLVX

CNBC Recommendations

Recent picks made for HLVX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in HLVX

Corporate Flights

Flights by private jets registered to HLVX